Russia will test the Covid-19 vaccine on volunteers this week, before distributing it to special groups in society.
“We will be kicking off a series of vaccinations for volunteers participating in Phase Three clinical trials this week,” Russian Health Minister Mikhail Murashko announced today.
The complete Covid-19 vaccine will be given priority to special groups in society such as health workers and teachers, and then mass vaccination will be introduced to residents nationwide, Russian health officials said. .
Two doses of vaccine Sputnik V. Photo: RDIF.
The Russian Direct Investment Fund (RDIF), which provides financial support to the Gamaleya Institute for Epidemiology and Microbiology Research, which develops the Sputnik V vaccine, said on Wednesday the preliminary results of the trial. clinical with the participation of 40,000 volunteers will be announced in October and November this year.
Sputnik V, developed by the Gameleya Institute in cooperation with the Russian Defense Ministry, became the first vaccine in the world approved by a government on August 11, in the context of the Covid-19 pandemic that many countries mobilized their efforts to research. Unprecedented rescue to rush the launch of a vaccine that could protect billions of people around the world. The vaccine was named “Sputnik V”, after the first satellite in the world “Sputnik 1” launched into space by the Soviet Union in 1957.
Dr Irina Dolzhikova, researcher at the Gamaleya Institute, said the results of Sputnik V Phase One and Two clinical trials showed no dangerous side effects by any standard, while side effects. of other vaccine candidates at 1-25%. Sputnik V vaccine trials conducted on animals, including Syrian hamsters and transgenic mice, showed 100% efficacy.
Phase three is an important test step on a scale of thousands of people, a necessary prerequisite for the vaccine to be approved by the regulator. Many Western countries are concerned that Russia has “burned up” in the vaccine development and licensed Sputnik V before conducting Phase Three trials. However, Minister Murashko confirmed that the vaccine’s skepticism was unfounded.
Russian officials say they are capable of producing up to 500 million doses of the Sputnik V vaccine in the next 12 months. Manufacturing is also expected to be conducted overseas and Phase Three clinical trials will be conducted